CAR T cell therapy in primary brain tumors: current investigations and the future

YJ Lin, LA Mashouf, M Lim - Frontiers in immunology, 2022 - frontiersin.org
Chimeric antigen receptor T cells (CAR T cells) are engineered cells expressing a chimeric
antigen receptor (CAR) against a specific tumor antigen (TA) that allows for the identification …

The biology of ependymomas and emerging novel therapies

AH Saleh, N Samuel, K Juraschka, MH Saleh… - Nature Reviews …, 2022 - nature.com
Ependymomas are rare central nervous system tumours that can arise in the brain's
supratentorial region or posterior fossa, or in the spinal cord. In 1924, Percival Bailey …

Choroid plexus mast cells drive tumor-associated hydrocephalus

Y Li, C Di, S Song, Y Zhang, Y Lu, J Liao, B Lei… - Cell, 2023 - cell.com
Tumor-associated hydrocephalus (TAH) is a common and lethal complication of brain
metastases. Although other factors beyond mechanical obstructions have been suggested …

Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q

LV Baroni, L Sundaresan, A Heled, H Coltin… - Neuro …, 2021 - academic.oup.com
Abstract Background Within PF-EPN-A, 1q gain is a marker of poor prognosis, however, it is
unclear if within PF-EPN-A additional cytogenetic events exist which can refine risk …

Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy

C Cacciotti, A Fleming… - The Journal of pathology, 2020 - Wiley Online Library
Central nervous system (CNS) tumors are the most common solid tumor in pediatrics,
accounting for approximately 25% of all childhood cancers, and the second most common …

[HTML][HTML] Cognitive risk in survivors of pediatric brain tumors

A Oyefiade, I Paltin, CR De Luca, KK Hardy… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Pediatric brain tumors (PBTs), the most common solid tumors of childhood, are a leading
cause of cancerrelated morbidity. Advancements in treatment have significantly improved …

Childhood malignant brain tumors: balancing the bench and bedside

C Thorbinson, JP Kilday - Cancers, 2021 - mdpi.com
Simple Summary Brain tumors remain the most common childhood solid tumors, accounting
for approximately 25% of all pediatric cancers. They also represent the most common cause …

Molecular grouping and outcomes of young children with newly diagnosed ependymoma treated on the multi-institutional SJYC07 trial

SA Upadhyaya, GW Robinson, A Onar-Thomas… - Neuro …, 2019 - academic.oup.com
Background This report documents the clinical characteristics, molecular grouping, and
outcome of young children with ependymoma treated prospectively on a clinical trial …

CAR T cell therapy for pediatric brain tumors

JD Patterson, JC Henson, RO Breese… - Frontiers in …, 2020 - frontiersin.org
Chimeric Antigen Receptor (CAR) T cell therapy has recently begun to be used for solid
tumors such as glioblastoma multiforme. Many children with pediatric malignant brain …

The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients

C Horbinski, KL Ligon, P Brastianos, JT Huse… - Neuro …, 2019 - academic.oup.com
Accurate pathologic diagnoses and molecularly informed treatment decisions for a wide
variety of cancers depend on robust clinical molecular testing that uses genomic …